(Q37179542)

18 August 2017

1 reference

title

Common variation in the CETP gene and the implications for cardiovascular disease and its treatment: an updated analysis (English)

1 reference

18 August 2017

main subject

cardiovascular disease

1 reference

Robin P F Dullaart

1

1 reference

18 August 2017

Wim J Sluiter

series ordinal

2

1 reference

18 August 2017

publication date

1 June 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

9

1 reference

18 August 2017

issue

6

1 reference

18 August 2017

page(s)

747-763

1 reference

The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

High-density lipoprotein--the clinical implications of recent studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Prevalence of risk factors in men with premature coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

HDL as a target in the treatment of atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

HDL and arteriosclerosis: beyond reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Lipid transfer proteins (LTP) and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Concerted actions of cholesteryl ester transfer protein and phospholipid transfer protein in type 2 diabetes: effects of apolipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Plasma cholesteryl ester transfer is a determinant of intima-media thickness in type 2 diabetic and nondiabetic subjects: role of CETP and triglycerides

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Cholesteryl ester transfer protein and its plasma regulator: lipid transfer inhibitor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Cholesteryl ester transfer protein: friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Is good cholesterol always good?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Importance of different pathways of cellular cholesterol efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Relative contributions of ABCA1 and SR-BI to cholesterol efflux to serum from fibroblasts and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Phospholipid transfer protein

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Remodelling of high density lipoproteins by plasma factors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Expression of cholesteryl ester transfer protein in human atherosclerotic lesions and its implication in reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Cholesteryl ester transfer protein directly mediates selective uptake of high density lipoprotein cholesteryl esters by the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Organization of the human cholesteryl ester transfer protein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

The two novel CETP mutations Gln87X and Gln165X in a compound heterozygous state are associated with marked hyperalphalipoproteinemia and absence of significant coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Inherited disorders of HDL metabolism and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

New functional promoter polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels: role of Sp1/Sp3 in transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Haplotype analysis of the CETP gene: not TaqIB, but the closely linked -629C-->A polymorphism and a novel promoter variant are independently associated with CETP concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

The effect of cholesteryl ester transfer protein -629C->A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the cardiovascular health study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

High-density lipoprotein subpopulations in pathologic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

LpA-I, LpA-I:A-II HDL and CHD-risk: The Framingham Offspring Study and the Veterans Affairs HDL Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Sex difference in the regulation of plasma high density lipoprotein cholesterol by genetic and environmental factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

The association between high-density lipoprotein cholesterol level and cholesteryl ester transfer protein TaqIB gene polymorphism is influenced by alcohol drinking in a population-based sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Cholesteryl ester transfer protein TaqIB polymorphism and its relation to parameters of the insulin resistance syndrome in an Austrian cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Decreased plasma cholesterol esterification and cholesteryl ester transfer in hypopituitary patients on glucocorticoid replacement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Common cholesteryl ester transfer protein gene polymorphisms and the effect of atorvastatin therapy in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Genetic and environmental determinants of plasma high density lipoprotein cholesterol and apolipoprotein AI concentrations in healthy middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Variation at the cholesteryl ester transfer protein gene in relation to plasma high density lipoproteins cholesterol levels and carotid intima-media thickness

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Alcohol consumption, TaqIB polymorphism of cholesteryl ester transfer protein, high-density lipoprotein cholesterol, and risk of coronary heart disease in men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

The -629C>A polymorphism in the CETP gene does not explain the association of TaqIB polymorphism with risk and age of myocardial infarction in Icelandic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

A polymorphism of the cholesteryl ester transfer protein gene predicts cardiovascular events in non-smokers in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Lack of association of the common TaqIB polymorphism in the cholesteryl ester transfer protein gene with angiographically assessed coronary atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Haplotypes of the cholesteryl ester transfer protein gene predict lipid-modifying response to statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqI

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

TaqIB polymorphism in CETP gene: the influence on incidence of cardiovascular disease in statin-treated patients with familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Pharmacogenetic study of apolipoprotein E, cholesteryl ester transfer protein and hepatic lipase genes and simvastatin therapy in Brazilian subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Genetic and environmental factors affecting the response to statin therapy in patients with molecularly defined familial hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

The association of common SNPs and haplotypes in the CETP and MDR1 genes with lipids response to fluvastatin in familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Pharmacogenetic study of cholesteryl ester transfer protein gene and simvastatin treatment in hypercholesterolaemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Response to micronized fenofibrate treatment is associated with the peroxisome-proliferator-activated receptors alpha G/C intron7 polymorphism in subjects with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Cholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European Prospective Investigation into Cancer and nutrition)-Norfolk population study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

High plasma cholesteryl ester transfer protein levels may favour reduced incidence of cardiovascular events in men with low triglycerides.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

CETP inhibition in cardiovascular risk management: a critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

The ability of plasma to stimulate fibroblast cholesterol efflux is associated with the -629C-->A cholesteryl ester transfer protein promoter polymorphism: role of lecithin: cholesterol acyltransferase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Newly identified loci that influence lipid concentrations and risk of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Effects of torcetrapib in patients at high risk for coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

The CETP TaqIB Polymorphism Is Associated With the Risk of Sudden Death in Type 2 Diabetic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Association between well-characterized lipoprotein-related genetic variants and carotid intimal medial thickness and stenosis: The Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

Variants in the cholesterol ester transfer protein and lipoprotein lipase genes are predictors of plasma cholesterol response to dietary change

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.747

21 January 2018

Identifiers

DOI

10.2217/14622416.9.6.747

1 reference

release_nskeub63tvaxtemfqqb4xj3lcm

18 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nskeub63tvaxtemfqqb4xj3lcm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference